Original BioMedicals Overview
- Year Founded
-
2011
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
2ndary - Open
- Financing Rounds
-
3
Original BioMedicals General Information
Description
Original Biomedicals Co Ltd is a drug development company. The Company is engaged in developing new chemical entities and creating novel drug carriers to enhance or repurpose previously approved products.
Contact Information
Website
www.i-obm.comCorporate Office
- 6F., No.415, Sec. 2
- Tiding Blvd., Neihu Dist.
- Taipei City, 114
- Taiwan
Corporate Office
- 6F., No.415, Sec. 2
- Tiding Blvd., Neihu Dist.
- Taipei City, 114
- Taiwan
Original BioMedicals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Original BioMedicals Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Original BioMedicals Patents
Original BioMedicals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023067795-A | Composition for upper respiratory tract administration and method for administration thereof | Active | 29-Oct-2021 | 0000000000 | |
| US-20230137888-A1 | Composition for upper respiratory tract administration and method thereof | Pending | 29-Oct-2021 | 0000000000 | |
| EP-4173618-A1 | Composition for upper respiratory tract administration comprising a metal chelator and a cyanide antidote and method thereof | Pending | 29-Oct-2021 | 0000000000 | 0 |
| AU-2022259787-A1 | Composition for upper respiratory tract administration and method thereof | Active | 29-Oct-2021 | 0000000000 | |
| CA-3179962-A1 | Composition for upper respiratory tract administration and method thereof | Pending | 29-Oct-2021 | A61K33/24 |
Original BioMedicals Executive Team (4)
| Name | Title | Board Seat |
|---|---|---|
| KD Wu | Chief Executive Officer & Chairman of the Board | |
| Hsiao-Pao Yen | Chief Operating Officer | |
| Duncan Chen | Chief Technology Officer & Board Member | |
| Cliff Wang | Chief Risk Officer & Board Member |
Original BioMedicals Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000 0000 | Original BioMedicals | Chief Risk Officer & Board Member | 000 0000 |
| 000000 0000 | Original BioMedicals | Chief Technology Officer & Board Member | 000 0000 |
| 00 00 | Original BioMedicals | Chief Executive Officer & Chairman of the Board | 000 0000 |
| 0000-00 000 | Self | Board Member | 000 0000 |
| 000-0000 0000 | Self | Board Member | 000 0000 |
Original BioMedicals Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Original BioMedicals Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Original BioMedicals FAQs
-
When was Original BioMedicals founded?
Original BioMedicals was founded in 2011.
-
Who is the CEO of Original BioMedicals?
KD Wu is the CEO of Original BioMedicals.
-
Where is Original BioMedicals headquartered?
Original BioMedicals is headquartered in Taipei City, Taiwan.
-
What is the size of Original BioMedicals?
Original BioMedicals has 15 total employees.
-
What industry is Original BioMedicals in?
Original BioMedicals’s primary industry is Drug Discovery.
-
Is Original BioMedicals a private or public company?
Original BioMedicals is a Private company.
-
What is Original BioMedicals’s current revenue?
The current revenue for Original BioMedicals is 000000.
-
How much funding has Original BioMedicals raised over time?
Original BioMedicals has raised $4.5M.
-
Who are Original BioMedicals’s investors?
Diamond Biofund has invested in Original BioMedicals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
